Collagen Peptides vs Undenatured Type II: Different Forms for Skin and Joints

Collagen supplements come in several distinct forms, and the form you choose matters because each is thought to work differently in the body. This guide explains what the research currently shows, how the two most common supplemental forms compare, and what safety considerations apply, drawing on data from the NIH Office of Dietary Supplements (ODS).

What Collagen Does in the Body

Collagen is the most abundant protein in the human body. According to the NIH ODS, it forms the structural framework of skin, bone, tendon, ligament, cartilage, and blood vessels, and it provides tensile strength and elasticity to connective tissue. This role is supported by strong evidence. When collagen is eaten, it is digested into amino acids and short peptides that contribute to the body's general amino acid pool, meaning the body does not automatically route dietary collagen directly back to skin or joints.

No adult daily target or upper limit for collagen has been established by the Dietary Reference Intake process, according to NIH ODS data.

Hydrolyzed Collagen Peptides

What They Are

Hydrolyzed collagen, also called collagen peptides or collagen hydrolysate, is produced by breaking whole collagen protein into smaller fragments using water and enzymes. The result is a powder that dissolves easily and is absorbed quickly in the digestive tract. Most products on the market are derived from bovine hide, porcine skin, or marine sources such as fish skin and scales.

Proposed Mechanism

Researchers propose that specific short peptides produced during digestion may reach the skin and joints through the bloodstream and signal fibroblast cells to increase their own collagen production. This hypothesis is still being studied, and the body of evidence is not yet conclusive.

What the Research Shows

• Skin outcomes (Moderate evidence): The NIH ODS rates the evidence as moderate that hydrolyzed collagen peptides may modestly improve skin measures such as elasticity, hydration, and wrinkle appearance. Most positive trials are short in duration and funded by supplement manufacturers, which introduces potential bias.
• Joint outcomes (Limited evidence): Collagen peptides may reduce joint discomfort or support joint function, including in osteoarthritis and exercise-related joint pain, but the NIH ODS rates this evidence as limited. Study designs, doses, and populations vary widely.
• Bone density (Limited evidence): Collagen supplementation may support bone mineral density, though again the NIH ODS classifies this as limited evidence, and it should not be understood as a substitute for established bone health strategies.
• Muscle mass combined with resistance exercise (Insufficient evidence): Collagen peptides combined with resistance exercise may increase muscle mass or strength, but the NIH ODS rates the current evidence as insufficient to draw conclusions.

Undenatured Type II Collagen

What It Is

Undenatured type II collagen (UC-II) is a different preparation entirely. Rather than being hydrolyzed into peptides, it is processed at low temperatures to preserve the three-dimensional structure of native type II collagen, which is the collagen found primarily in cartilage. Most commercial UC-II is derived from chicken sternum cartilage and is used at much lower doses than hydrolyzed collagen, typically in the range of 10 to 40 milligrams per day in clinical studies, compared with several grams per day for peptide products.

Proposed Mechanism

The proposed mechanism for UC-II is oral tolerance. The idea is that small amounts of intact type II collagen, encountered by immune tissue in the gut, may reduce the immune system's inflammatory response toward cartilage collagen in joints. This is a different pathway from the amino acid or peptide signaling proposed for hydrolyzed collagen, and it is the subject of ongoing research.

What the Research Shows

The NIH ODS places joint outcomes for both collagen peptides and undenatured type II collagen under the same limited evidence category, noting that either form may reduce joint discomfort or support joint function in osteoarthritis and exercise-related joint pain. Clinical trials on UC-II have shown some promising results in people with knee osteoarthritis and in athletes, but study populations are often small and follow-up periods are short.

Safety and Tolerability

According to the NIH ODS, collagen supplements are generally regarded as well tolerated in short-term studies, with only mild gastrointestinal side effects reported. There are no significant, well-documented drug interactions listed by NIH ODS or the National Center for Complementary and Integrative Health (NCCIH).

Key cautions include the following:

• Allergen sources: Marine collagen may affect people with fish or shellfish allergies. Bovine and porcine collagen may affect those with specific animal-protein allergies. UC-II from chicken cartilage may be a concern for people with poultry-related sensitivities. Always check the source listed on the label.
• Protein intake: As a protein source, collagen adds to total dietary protein intake. This is a consideration for people on protein-restricted diets for advanced kidney or liver disease.
• Combined products: Some collagen products include added ingredients such as vitamin C, biotin, or herbal extracts. Check the full label for potential interactions from those added components, and talk to a doctor or pharmacist before combining any supplement with medication.
• Regulatory status: Supplements are not FDA-approved before sale, so purity, dose, and source can vary between products. These statements have not been evaluated by the FDA, and supplements are not intended to diagnose, treat, cure, or prevent any disease.

How to Choose Between the Two Forms

Hydrolyzed collagen peptides are more commonly studied for skin outcomes and are used at higher doses. Undenatured type II collagen is studied specifically for joint cartilage and is used at much lower doses through a different proposed mechanism. Neither form has an established daily target from the Dietary Reference Intake process.

The honest summary is that both forms show some early positive signals in research, but the evidence for both is rated limited or moderate at best by the NIH ODS, and longer, larger, independent trials are still needed.

Talking to Your Clinician

Because no official dosing target exists, and because individual health circumstances vary, please consult a clinician or pharmacist for personal dosing guidance before starting either form of collagen supplement. This is especially important if you have kidney or liver disease, known food allergies, or are taking prescription medications.